TipRanks
Keros Therapeutics (KROS)
NASDAQ:KROS
US Market
KROS
Keros Therapeutics
RESEARCH TOOLSreports
Want to see KROS full AI Analyst Report?

Keros Therapeutics (KROS) Ratios

370 Followers

Keros Therapeutics Ratios

KROS's free cash flow for Q2 2026 was $0.00. For the 2026 fiscal year, KROS's free cash flow was decreased by $ and operating cash flow was $0.00. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
 21.96 15.45 21.45 14.25 17.27
Quick Ratio
 21.96 15.45 21.45 14.25 17.27
Cash Ratio
 21.20 14.08 20.40 13.59 16.86
Solvency Ratio
 -3.23 2.54 -4.20 -4.02 -3.54
Operating Cash Flow Ratio
 -3.95 5.27 -5.86 -5.11 -4.23
Short-Term Operating Cash Flow Coverage
 -18.48 0.00 0.00 0.00 0.00
Net Current Asset Value
$ 241.60M$ 280.55M$ 544.56M$ 309.48M$ 256.41M
Leverage Ratios
Debt-to-Assets Ratio
 0.05 0.05 0.03 0.04 0.04
Debt-to-Equity Ratio
 0.06 0.06 0.03 0.04 0.05
Debt-to-Capital Ratio
 0.06 0.05 0.03 0.04 0.05
Long-Term Debt-to-Capital Ratio
 0.05 0.00 0.00 0.00 0.00
Financial Leverage Ratio
 1.10 1.12 1.08 1.11 1.11
Debt Service Coverage Ratio
 -31.41 0.00 0.00 0.00 -104.00K
Interest Coverage Ratio
 0.00 0.00 0.00 0.00 -114.79K
Debt to Market Cap
 0.07 0.00 0.00 0.00 0.00
Interest Debt Per Share
 0.79 0.45 0.50 0.49 0.53
Net Debt to EBITDA
 2.86 -2.90 2.91 2.08 2.56
Profitability Margins
Gross Profit Margin
94.68%99.38%100.00%100.00%0.00%
EBIT Margin
-573.44%37.65%-5269.10%-101319.21%0.00%
EBITDA Margin
-562.79%38.27%-5234.48%-100779.47%0.00%
Operating Profit Margin
-675.82%28.94%-5938.96%-112543.71%0.00%
Pretax Profit Margin
-573.44%37.65%-5269.10%-101319.21%0.00%
Net Profit Margin
-553.88%35.65%-5277.55%-101319.21%0.00%
Continuous Operations Profit Margin
-553.88%35.65%-5277.55%-101319.21%0.00%
Net Income Per EBT
96.59%94.69%100.16%100.00%100.00%
EBT Per EBIT
84.85%130.12%88.72%90.03%91.19%
Return on Assets (ROA)
-28.91%25.74%-30.42%-41.35%-34.12%
Return on Equity (ROE)
-21.40%28.70%-32.78%-46.05%-37.73%
Return on Capital Employed (ROCE)
-36.84%22.24%-35.83%-49.17%-39.55%
Return on Invested Capital (ROIC)
-35.25%20.90%-35.71%-49.02%-39.49%
Return on Tangible Assets
-28.91%25.74%-30.42%-41.35%-34.12%
Earnings Yield
-36.84%11.48%-31.61%-13.07%-8.64%
Efficiency Ratios
Receivables Turnover
 5.45 38.30 0.80 0.14 0.00
Payables Turnover
 0.44 0.77 0.00 0.00 0.00
Inventory Turnover
 0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover
 0.78 11.55 0.15 <0.01 0.00
Asset Turnover
 0.05 0.72 <0.01 <0.01 0.00
Working Capital Turnover Ratio
 0.06 0.57 <0.01 <0.01 0.00
Cash Conversion Cycle
 -763.60 -466.25 458.15 2.64K 0.00
Days of Sales Outstanding
 67.02 9.53 458.15 2.64K 0.00
Days of Inventory Outstanding
 0.00 0.00 0.00 0.00 0.00
Days of Payables Outstanding
 830.63 475.78 0.00 0.00 0.00
Operating Cycle
 67.02 9.53 458.15 2.64K 0.00
Cash Flow Ratios
Operating Cash Flow Per Share
 -2.42 2.89 -4.30 -4.23 -2.78
Free Cash Flow Per Share
 -2.45 2.85 -4.35 -4.31 -2.82
CapEx Per Share
 0.02 0.04 0.05 0.08 0.05
Free Cash Flow to Operating Cash Flow
 1.01 0.99 1.01 1.02 1.02
Dividend Paid and CapEx Coverage Ratio
 -97.15 69.31 -83.31 -50.53 -56.46
Capital Expenditure Coverage Ratio
 -97.15 69.31 -83.31 -50.53 -56.46
Operating Cash Flow Coverage Ratio
 -3.05 6.37 -8.53 -8.62 -5.28
Operating Cash Flow to Sales Ratio
 -3.20 0.44 -45.32 -824.56 0.00
Free Cash Flow Yield
-21.45%13.98%-27.47%-10.84%-5.88%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 -3.08 8.70 -3.17 -7.65 -11.58
Price-to-Sales (P/S) Ratio
 15.05 3.11 166.94 7.75K 0.00
Price-to-Book (P/B) Ratio
 0.86 2.50 1.04 3.52 4.37
Price-to-Free Cash Flow (P/FCF) Ratio
 -4.66 7.15 -3.64 -9.22 -17.00
Price-to-Operating Cash Flow Ratio
 -4.70 7.05 -3.68 -9.40 -17.30
Price-to-Earnings Growth (PEG) Ratio
 <0.01 -0.06 0.82 -0.30 -0.18
Price-to-Fair Value
 0.86 2.50 1.04 3.52 4.37
Enterprise Value Multiple
 0.19 5.22 -0.28 -5.61 -9.10
Enterprise Value
 -15.85M 487.29M 51.57M 854.11M 946.29M
EV to EBITDA
 0.19 5.22 -0.28 -5.61 -9.10
EV to Sales
 -1.06 2.00 14.53 5.66K 0.00
EV to Free Cash Flow
 0.33 4.60 -0.32 -6.73 -13.27
EV to Operating Cash Flow
 0.33 4.53 -0.32 -6.86 -13.51
Tangible Book Value Per Share
 13.25 8.14 15.27 11.28 10.99
Shareholders’ Equity Per Share
 13.25 8.14 15.27 11.28 10.99
Tax and Other Ratios
Effective Tax Rate
 0.03 0.05 >-0.01 0.00 0.00
Revenue Per Share
 0.76 6.56 0.09 <0.01 0.00
Net Income Per Share
 -4.20 2.34 -5.00 -5.20 -4.15
Tax Burden
 0.97 0.95 1.00 1.00 1.00
Interest Burden
 1.00 1.00 1.00 1.00 1.00
Research & Development to Revenue
 5.05 0.53 48.91 895.75 0.00
SG&A to Revenue
 2.71 0.19 11.48 230.69 0.00
Stock-Based Compensation to Revenue
 1.52 0.12 9.82 190.48 0.00
Income Quality
 0.58 1.24 0.86 0.81 0.67
Currency in USD